Navidea Biopharmaceuticals Inc (NAVB)
0.0392
0.00 (0.00%)
USD |
OTCM |
May 08, 16:00
Navidea Biopharmaceuticals Free Cash Flow: -9.907M for Sept. 30, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
September 30, 2023 | -9.907M |
June 30, 2023 | -1.578M |
March 31, 2023 | -8.464M |
December 31, 2022 | -9.377M |
September 30, 2022 | -9.690M |
June 30, 2022 | -9.898M |
March 31, 2022 | -10.09M |
December 31, 2021 | -10.55M |
September 30, 2021 | -10.37M |
June 30, 2021 | -11.06M |
March 31, 2021 | -10.70M |
December 31, 2020 | -8.588M |
September 30, 2020 | -8.682M |
June 30, 2020 | -8.186M |
March 31, 2020 | -8.205M |
December 31, 2019 | -9.355M |
September 30, 2019 | -8.776M |
June 30, 2019 | -8.336M |
March 31, 2019 | 4.324M |
December 31, 2018 | 4.229M |
September 30, 2018 | 4.419M |
June 30, 2018 | 5.352M |
March 31, 2018 | -10.87M |
December 31, 2017 | 59.05M |
September 30, 2017 | 63.27M |
Date | Value |
---|---|
June 30, 2017 | 66.90M |
March 31, 2017 | 72.90M |
December 31, 2016 | 3.555M |
September 30, 2016 | -2.906M |
June 30, 2016 | -9.671M |
March 31, 2016 | -16.71M |
December 31, 2015 | -19.14M |
September 30, 2015 | -19.79M |
June 30, 2015 | -22.43M |
March 31, 2015 | -24.27M |
December 31, 2014 | -30.32M |
September 30, 2014 | -37.12M |
June 30, 2014 | -40.18M |
March 31, 2014 | -39.32M |
December 31, 2013 | -36.90M |
September 30, 2013 | -32.61M |
June 30, 2013 | -28.12M |
March 31, 2013 | -25.62M |
December 31, 2012 | -24.60M |
September 30, 2012 | -27.03M |
June 30, 2012 | -25.50M |
March 31, 2012 | -21.13M |
December 31, 2011 | -16.25M |
September 30, 2011 | -8.072M |
June 30, 2011 | -5.553M |
Free Cash Flow Range, Past 5 Years
-11.06M
Minimum
Jun 2021
-1.578M
Maximum
Jun 2023
-8.990M
Average
-9.366M
Median
Free Cash Flow Benchmarks
Perspective Therapeutics Inc | -37.98M |
Electromed Inc | 3.653M |
Xtant Medical Holdings Inc | -10.97M |
Asensus Surgical Inc | -64.19M |
Senseonics Holdings Inc | -70.51M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -10.25M |
Cash from Investing (Quarterly) | -0.5247M |
Cash from Financing (Quarterly) | -0.1886M |
Free Cash Flow Per Share (Quarterly) | -0.1033 |
Free Cash Flow Yield | -475.4% |